Have a feature idea you'd love to see implemented? Let us know!
Back to ACAD overview

ACAD Acadia Pharmaceuticals PE ratio, current and historical analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACAD
  4. PE Ratio

The P/E ratio for Acadia Pharmaceuticals stock stands at 22.27 as of Dec 26, 2024. The calculation is based on the latest EPS of $0.78 and the stock price of $17.37 per share.

ACAD PE ratio history

How has ACAD's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Acadia Pharmaceuticals PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

ACAD average PE ratio chart

What is the average PE ratio of ACAD for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

ACAD PE vs peers

What is ACAD's PE ratio compared to its peers

When compared to its peer stocks LLY and JNJ, ACAD's PE ratio is lower.

Stock name PE ratio Market cap
ACAD Acadia Pharmaceuticals Inc 22.27 $2.89B
JNJ Johnson & Johnson 24.14 $350.5B
PFE Pfizer Inc 34.95 $150.52B
LLY ELI LILLY & Co 85.48 $753.89B
VNDA Vanda Pharmaceuticals Inc N/A $280.46M
BMY Bristol Myers Squibb Co N/A $117.63B

Frequently asked questions

What is Acadia Pharmaceuticals's PE ratio?

The price to earnings ratio for ACAD stock as of Dec 26, 2024, stands at 22.27.

How is ACAD's PE ratio calculated (Acadia Pharmaceuticals PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Dec 26, 2024), Acadia Pharmaceuticals's share price is $17.37. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.78. Therefore, Acadia Pharmaceuticals's price to earnings ratio for today is 22.27. PE RATIO(22.27) = STOCK PRICE($17.37) / TTM EPS($0.78)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.